amlodipine has been researched along with Recrudescence in 15 studies
Amlodipine: A long-acting dihydropyridine calcium channel blocker. It is effective in the treatment of ANGINA PECTORIS and HYPERTENSION.
amlodipine : A fully substituted dialkyl 1,4-dihydropyridine-3,5-dicarboxylate derivative, which is used for the treatment of hypertension, chronic stable angina and confirmed or suspected vasospastic angina.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study compared the effect of antihypertensive treatment with valsartan or ramipril on atrial fibrillation (AF) recurrence, on P-wave dispersion, (PWD) and on serum procollagen type I carboxy terminal peptide (PIP)." | 9.13 | Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation. ( Corradi, L; Derosa, G; Ferrari, I; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Santoro, T; Zoppi, A, 2008) |
| "The aim of the study was to evaluate the effect of losartan as compared with amlodipine, both associated with amiodarone, in preventing the recurrence of atrial fibrillation (AF) in hypertensive patients with a history of recent paroxysmal atrial fibrillation." | 9.12 | Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. ( Corradi, L; Destro, M; Fogari, E; Fogari, R; Mugellini, A; Rinaldi, A; Zoppi, A, 2006) |
| "Amlodipine is generally safe in subjects with HP and does not increase pain or episodes of AP." | 9.12 | Hereditary pancreatitis amlodipine trial: a pilot study of a calcium-channel blocker in hereditary pancreatitis. ( Elinoff, BD; Lowe, ME; Morinville, VD; Whitcomb, DC, 2007) |
| "Telmisartan was more effective than amlodipine in preventing AF recurrences in hypertensive patients with paroxysmal AF." | 6.77 | Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size. ( Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Perrone, T; Preti, P; Zoppi, A, 2012) |
| "This study compared the effect of antihypertensive treatment with valsartan or ramipril on atrial fibrillation (AF) recurrence, on P-wave dispersion, (PWD) and on serum procollagen type I carboxy terminal peptide (PIP)." | 5.13 | Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation. ( Corradi, L; Derosa, G; Ferrari, I; Fogari, R; Lazzari, P; Mugellini, A; Preti, P; Santoro, T; Zoppi, A, 2008) |
| "The aim of the study was to evaluate the effect of losartan as compared with amlodipine, both associated with amiodarone, in preventing the recurrence of atrial fibrillation (AF) in hypertensive patients with a history of recent paroxysmal atrial fibrillation." | 5.12 | Losartan and prevention of atrial fibrillation recurrence in hypertensive patients. ( Corradi, L; Destro, M; Fogari, E; Fogari, R; Mugellini, A; Rinaldi, A; Zoppi, A, 2006) |
| "Amlodipine is generally safe in subjects with HP and does not increase pain or episodes of AP." | 5.12 | Hereditary pancreatitis amlodipine trial: a pilot study of a calcium-channel blocker in hereditary pancreatitis. ( Elinoff, BD; Lowe, ME; Morinville, VD; Whitcomb, DC, 2007) |
| "The Coronary AngioPlasty Amlodipine REStenosis Study (CAPARES) is a multicentre, double-blind, placebo controlled restenosis trial investigating the effect of amlodipine on angiographic and clinical endpoints in patients undergoing routine percutaneous transluminal coronary angioplasty (PTCA) for stable angina pectoris." | 5.09 | Results and clinical implications of the CAPARES trial. ( Jorgensen, B; Thaulow, E, 2000) |
| "Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto (SILK study) is a prospective, multicenter, randomized, and open-label comparative evaluation of the effects of irbesartan and amlodipine on AF recurrence in hypertensive patients with AF who are scheduled to undergo catheter ablation or electrical cardioversion of AF." | 3.88 | Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study). ( Fujimoto, K; Iwasa, A; Kaikita, K; Kajiwara, I; Koyama, J; Matsui, K; Matsumura, T; Morihisa, K; Morikami, Y; Ogawa, H; Tsujita, K; Tsunoda, R; Uemura, T; Yamabe, H, 2018) |
| "Telmisartan was more effective than amlodipine in preventing AF recurrences in hypertensive patients with paroxysmal AF." | 2.77 | Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size. ( Derosa, G; Fogari, R; Maffioli, P; Mugellini, A; Perrone, T; Preti, P; Zoppi, A, 2012) |
| "Hypertension is the most prevalent and potentially modifiable risk factor for AF." | 2.72 | Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis. ( Feng, J; Gan, Y; Jiang, H; Ma, H, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (20.00) | 18.2507 |
| 2000's | 8 (53.33) | 29.6817 |
| 2010's | 3 (20.00) | 24.3611 |
| 2020's | 1 (6.67) | 2.80 |
| Authors | Studies |
|---|---|
| Ma, H | 1 |
| Jiang, H | 1 |
| Feng, J | 1 |
| Gan, Y | 1 |
| Patel, P | 1 |
| Yau, C | 1 |
| Kurian, J | 1 |
| Yamabe, H | 1 |
| Kaikita, K | 1 |
| Matsumura, T | 1 |
| Iwasa, A | 1 |
| Koyama, J | 1 |
| Uemura, T | 1 |
| Morikami, Y | 1 |
| Tsunoda, R | 1 |
| Morihisa, K | 1 |
| Fujimoto, K | 1 |
| Kajiwara, I | 1 |
| Matsui, K | 1 |
| Tsujita, K | 1 |
| Ogawa, H | 1 |
| Fogari, R | 3 |
| Derosa, G | 2 |
| Ferrari, I | 1 |
| Corradi, L | 2 |
| Zoppi, A | 3 |
| Lazzari, P | 1 |
| Santoro, T | 1 |
| Preti, P | 2 |
| Mugellini, A | 3 |
| Maffioli, P | 1 |
| Perrone, T | 1 |
| Obiechina, NS | 1 |
| Fine, JB | 1 |
| Jørgensen, B | 1 |
| Thaulow, E | 4 |
| Destro, M | 1 |
| Fogari, E | 1 |
| Rinaldi, A | 1 |
| Zambrana García, JL | 1 |
| Montijano Cabrera, AM | 1 |
| Adarraga Cansino, MD | 1 |
| Rosa Jiménez, F | 1 |
| Higashide, T | 1 |
| Okai, T | 1 |
| Yoshida, S | 1 |
| Tonoike, N | 1 |
| Kakihara, M | 1 |
| Mizumura, T | 1 |
| Oshima, A | 1 |
| Sugimura, Y | 1 |
| Tamamura, T | 1 |
| Ogata, I | 1 |
| Morinville, VD | 1 |
| Lowe, ME | 1 |
| Elinoff, BD | 1 |
| Whitcomb, DC | 1 |
| Jörgensen, B | 3 |
| Gurm, HS | 1 |
| Farooq, M | 1 |
| Simonsen, S | 1 |
| Endresen, K | 1 |
| Forfang, K | 1 |
| Egeland, T | 1 |
| Høstmark, AT | 1 |
2 reviews available for amlodipine and Recrudescence
| Article | Year |
|---|---|
Angiotensin Receptor Blocker and Calcium Channel Blocker Preventing Atrial Fibrillation Recurrence in Patients with Hypertension and Atrial Fibrillation: A Meta-analysis.
Topics: Amlodipine; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Atrial Fibri | 2021 |
Clinical promise of calcium antagonists in the angioplasty patient.
Topics: Amlodipine; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Combined Modality Therapy; Cor | 1997 |
7 trials available for amlodipine and Recrudescence
| Article | Year |
|---|---|
Effect of valsartan and ramipril on atrial fibrillation recurrence and P-wave dispersion in hypertensive patients with recurrent symptomatic lone atrial fibrillation.
Topics: Aged; Amlodipine; Antihypertensive Agents; Atrial Fibrillation; Double-Blind Method; Electrocardiogr | 2008 |
Effect of telmisartan on paroxysmal atrial fibrillation recurrence in hypertensive patients with normal or increased left atrial size.
Topics: Aged; Amlodipine; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atrial Fibrilla | 2012 |
Effects of amlodipine on ischemia after percutaneous transluminal coronary angioplasty: secondary results of the Coronary Angioplasty Amlodipine Restenosis (CAPARES) Study.
Topics: Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Coronary Angi | 2003 |
Losartan and prevention of atrial fibrillation recurrence in hypertensive patients.
Topics: Adult; Aged; Amlodipine; Antihypertensive Agents; Atrial Fibrillation; Double-Blind Method; Female; | 2006 |
Hereditary pancreatitis amlodipine trial: a pilot study of a calcium-channel blocker in hereditary pancreatitis.
Topics: Acute Disease; Adolescent; Adult; Amlodipine; Analgesics; Blood Pressure; Calcium Channel Blockers; | 2007 |
Luminal loss and restenosis after coronary angioplasty. The role of lipoproteins and lipids.
Topics: Amlodipine; Angioplasty, Balloon, Coronary; Coronary Angiography; Coronary Disease; Female; Humans; | 1999 |
Results and clinical implications of the CAPARES trial.
Topics: Amlodipine; Angina Pectoris; Angioplasty, Balloon, Coronary; Calcium Channel Blockers; Coronary Angi | 2000 |
6 other studies available for amlodipine and Recrudescence
| Article | Year |
|---|---|
ST elevation myocardial infarction after coronary artery spasm with no clear trigger.
Topics: Amlodipine; Arrhythmias, Cardiac; Cardiopulmonary Resuscitation; Coronary Angiography; Coronary Vaso | 2017 |
Study on the Effect of Irbesartan on Atrial Fibrillation Recurrence in Kumamoto: Atrial Fibrillation Suppression Trial (SILK study).
Topics: Aged; Amlodipine; Angiotensin Receptor Antagonists; Atrial Fibrillation; Biphenyl Compounds; Blood P | 2018 |
Case report: treatment of amlodipine associated gingival overgrowth in periodontitis patients.
Topics: Alveolar Bone Loss; Amlodipine; Antihypertensive Agents; Chronic Disease; Dental Calculus; Dental Sc | 2000 |
[Recurrent syncopes secondary to pheochromocytoma].
Topics: Adrenal Gland Neoplasms; Adrenergic alpha-Antagonists; Aged; Amlodipine; Antihypertensive Agents; Do | 2007 |
[Basedow disease with recurrent syncopal attack and severe pulmonary hypertension].
Topics: Aged; Amlodipine; Atrial Fibrillation; Digoxin; Female; Graves Disease; Humans; Hypertension, Pulmon | 2007 |
Calcium channel blockers and benign hypertension.
Topics: Amlodipine; Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hypertension; Intracr | 1999 |